MedWatch

Lundbeck CEO: No money in Teva settlement

There was no money involved in the secret settlement between Lundbeck and generics giant Teva, says CEO Ulf Wiinberg. He refuses to reveal whether other types of assets have changed hands.

Foto: Mik Eskestad, Jyllands-Posten

The CEO denies that money should be involved in the settlement agreement with one of the company’s biggest generics rivals. But whether other types of assets have been transferred between the companies, he refuses to comment on.

Last week MedWatch revealed the secret settlement agreement between the two companies. The agreement effectively suspends all current court disputes involving Lundbeck and Teva, or any of its subsidiaries, and protects the Danish companies blockbuster-drug Cipralex from patent law suits.

Allerede abonnent? Log ind.

Læs hele artiklen

Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier